CONSORT 2010, explanation and elaboration Updated guidelines for reporting parallel group randomized trials

被引:0
|
作者
不详
机构
来源
ARCHIVES OF HELLENIC MEDICINE | 2011年 / 28卷
关键词
Bias; CONSORT statement; Critical appraisal; Quality; Randomized controlled trial (RCT); Systematic error; Transparency;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Overwhelming evidence shows that the quality of reporting of randomized controlled trials (RCTs) is not optimal. Without transparent reporting, readers can neither judge the reliability and validity of trial findings nor extract valid information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimize or avoid bias. A group of scientists and editors developed the Consolidated Standards of Reporting Trials (CONSORT) statement to improve the quality of reporting of RCTs. This was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement was further revised and published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document - intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item, providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 statement, this revised explanatory and elaboration document, and the associated website (www. consort-statement. org) should be helpful resources for improving the reporting of randomized trials.
引用
收藏
页码:10 / 59
页数:50
相关论文
共 50 条
  • [41] A Systematic Review of Completeness of Reporting in Randomized Controlled Trials in Dermatologic Surgery: Adherence to CONSORT 2010 Recommendations
    Alam, Murad
    Rauf, Mutahir
    Ali, Sana
    Patel, Parth
    Schlessinger, Daniel I.
    Schaeffer, Matthew R.
    Yoo, Simon S.
    Minkis, Kira
    Jiang, Shang I. Brian
    Maher, Ian A.
    Sobanko, Joseph F.
    Cartee, Todd V.
    Poon, Emily
    DERMATOLOGIC SURGERY, 2016, 42 (12) : 1325 - 1334
  • [42] Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy
    Bylicki, O.
    Gan, H. K.
    Joly, F.
    Maillet, D.
    You, B.
    Peron, J.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 231 - 237
  • [43] Completeness of Reporting in Randomized Controlled Trials of 3 Vaccines: A Review of Adherence to the CONSORT Checklist
    Scott, Pippa
    Ott, Franziska
    Egger, Matthias
    Low, Nicola
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (12) : 1286 - 1294
  • [44] An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review
    Stevely, Abigail
    Dimairo, Munyaradzi
    Todd, Susan
    Julious, Steven A.
    Nicholl, Jonathan
    Hind, Daniel
    Cooper, Cindy L.
    PLOS ONE, 2015, 10 (11):
  • [45] The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting
    Bagul, Nitin Babulal
    Kirkham, Jamie J.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34 (08) : 548 - 554
  • [46] Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review
    Peron, Julien
    Maillet, Denis
    Gan, Hui K.
    Chen, Eric X.
    You, Benoit
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) : 3957 - +
  • [47] A New Policy to Implement CONSORT Guidelines for Surgical Randomized Controlled Trials
    Clavien, Pierre-Alain
    Lillemoe, Keith D.
    ANNALS OF SURGERY, 2014, 260 (06) : 947 - 948
  • [48] The REFLECT Statement: Methods and Processes of Creating Reporting Guidelines for Randomized Controlled Trials for Livestock and Food Safety by Modifying the CONSORT Statement†
    O'Connor, A. M.
    Sargeant, J. M.
    Gardner, I. A.
    Dickson, J. S.
    Torrence, M. E.
    ZOONOSES AND PUBLIC HEALTH, 2010, 57 (02) : 95 - 104
  • [49] The degree of adherence to CONSORT reporting guidelines for the abstracts of randomised clinical trials published in anaesthesia journals A cross-sectional study of reporting adherence in 2010 and 2016
    Chow, Jeffrey T. Y.
    Turkstra, Timothy P.
    Yim, Edmund
    Jones, Philip M.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2018, 35 (12) : 942 - 948
  • [50] Impact of the CONSORT Statement endorsement in the completeness of reporting of randomized clinical trials in restorative dentistry
    Sarkis-Onofre, Rafael
    Poletto-Neto, Victorio
    Cenci, Maximiliano Sergio
    Pereira-Cenci, Tatiana
    Moher, David
    JOURNAL OF DENTISTRY, 2017, 58 : 54 - 59